BRIEF published on 11/10/2025 at 21:55, 1 month 11 days ago Integrated BioPharma publie ses résultats financiers pour le troisième trimestre 2025 Résultats Financiers Baisse Des Revenus Résultat D'exploitation Revenu Net Fabrication Sous Contrat
BRIEF published on 11/10/2025 at 21:55, 1 month 11 days ago Integrated BioPharma Reports Financial Results for Q3 2025 Financial Results Net Income Revenue Decline Operating Income Contract Manufacturing
PRESS RELEASE published on 11/10/2025 at 21:50, 1 month 11 days ago Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2025 Integrated BioPharma, Inc. reports financial results for the quarter ended September 30, 2025, with $12.7 million revenue and insights on operating income and net income Financial Results Revenue Net Income Operating Income Integrated BioPharma
BRIEF published on 09/23/2025 at 21:45, 2 months 28 days ago Integrated BioPharma Reports Fiscal Year 2025 Results Financial Results Revenue Growth Net Income Operating Income Contract Manufacturing
BRIEF published on 09/23/2025 at 21:45, 2 months 28 days ago Integrated BioPharma publie ses résultats pour l'exercice 2025 Résultats Financiers Croissance Des Revenus Résultat D'exploitation Revenu Net Fabrication Sous Contrat
PRESS RELEASE published on 09/23/2025 at 21:40, 2 months 28 days ago Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2025 Integrated BioPharma, Inc. reports 11.8% increase in revenue for Q2 2025. Operating income rises in Q2 & FY 2025. Net loss in Q2 but net income grows for FY 2025 Revenue Increase Net Income Net Loss Operating Income Integrated BioPharma
BRIEF published on 05/14/2025 at 21:35, 7 months 7 days ago Integrated BioPharma, Inc. publie ses résultats financiers pour le premier trimestre 2025 Résultats Financiers Croissance Des Revenus Résultat D'exploitation T1 2025 Principaux Clients
BRIEF published on 05/14/2025 at 21:35, 7 months 7 days ago Integrated BioPharma, Inc. Posts Financial Results for Q1 2025 Financial Results Revenue Growth Operating Income Q1 2025 Key Customers
PRESS RELEASE published on 05/14/2025 at 21:30, 7 months 7 days ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025 Integrated BioPharma, Inc. reports a 6.1% revenue increase for Q1 2025 compared to Q1 2024. Company had operating income and net income growth. Key focus on core business and expanding customer base Financial Results Revenue Increase Net Income Operating Income Integrated BioPharma
BRIEF published on 02/13/2025 at 22:00, 10 months 8 days ago Integrated BioPharma Reports Quarterly Results with Increased Revenue Revenue Growth Q4 Results Operating Income Customer Base Expansion Integrated BioPharma
Published on 12/22/2025 at 08:05, 1 hour 45 minutes ago Tocvan Begins Trenching Material for the Pilot Mine and Pushes Ahead With Infrastructure Development
Published on 12/20/2025 at 00:30, 2 days 9 hours ago Alphinat Announces a Profit of $120,155 for Fiscal Year Ended August 31, 2025
Published on 12/19/2025 at 22:00, 2 days 11 hours ago GMV Minerals Inc. Closes Non-Brokered Equity Financing
Published on 12/19/2025 at 18:30, 2 days 15 hours ago Eagle Plains Shareholders Approve all Matters at Annual General Meeting
Published on 12/19/2025 at 14:40, 2 days 19 hours ago Northern Superior Announces Closing of the Arrangement
Published on 12/22/2025 at 09:30, 20 minutes ago Huawei's MoM-based Multi-Agent Collaboration System Empowers Core Networks' Transitioning to L4 High Stability
Published on 12/22/2025 at 09:22, 28 minutes ago Heirs Energies Agrees $750m Afreximbank Financing to Drive Long-Term Growth
Published on 12/22/2025 at 09:22, 28 minutes ago Heirs Energies conclut un accord de financement de 750 millions USD avec Afreximbank pour stimuler sa croissance à long terme
Published on 12/22/2025 at 09:00, 49 minutes ago Original-Research: Cantourage Group SE (von NuWays AG): BUY
Published on 12/22/2025 at 09:18, 32 minutes ago GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 11/12/2025
Published on 12/22/2025 at 09:18, 32 minutes ago GUILLEMOT CORPORATION : Informations relatives au nombre total de droits de vote et d’actions 11/12/2025
Published on 12/19/2025 at 21:57, 2 days 11 hours ago Mise à disposition du document d’enregistrement universel
Published on 12/19/2025 at 08:30, 3 days 1 hour ago Share capital decrease by way of treasury shares cancellation
Published on 12/19/2025 at 08:30, 3 days 1 hour ago Réduction du capital par voie d’annulation d’actions propres
